RSS
BDSI

Rosenblum Silverman Sutton’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Rosenblum Silverman Sutton’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$1.44M Buy
120,050
+34,750
+41% +$528K 0.62% 48
2014
Q3 		$1.46M Buy
+85,300
New +$1.24M 0.66% 48

Other funds holding BDSI

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Rosenblum Silverman Sutton's BDSI Position: Q4 2014 in Review

Rosenblum Silverman Sutton increased its BioDelivery Sciences International, Inc. (BDSI) stake by 41% in Q4 2014, buying an estimated $528K and bringing the position to 120,050 shares worth $1.44M. The position accounts for 0.62% of the portfolio, ranked #48.

Rosenblum Silverman Sutton first reported a position in BDSI in Q3 2014 and has held it in 2 quarters since. The position peaked at $1.46M in Q3 2014. 135 funds tracked by Wall St. Rank hold BDSI as of Q4 2014.

  • Rosenblum Silverman Sutton held 120,050 shares of BioDelivery Sciences International, Inc. worth $1.44M as of Q4 2014.
  • Rosenblum Silverman Sutton bought 34,750 BioDelivery Sciences International, Inc. shares in Q4 2014, an estimated $528K.
  • BioDelivery Sciences International, Inc. made up 0.62% of Rosenblum Silverman Sutton's portfolio in Q4 2014, its #48 holding.
  • Rosenblum Silverman Sutton first reported a position in BioDelivery Sciences International, Inc. in Q3 2014 and has held it in 2 quarters since.
  • Rosenblum Silverman Sutton's BioDelivery Sciences International, Inc. position peaked at $1.46M in Q3 2014.
  • 135 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2014.

Based on Rosenblum Silverman Sutton's 13F filing for Q4 2014, filed 17 Feb 2015.